Anacetrapib

Overview

Anacetrapib is a potent CETP inhibitor, with IC 50 s of 7.9±2.5 nM and 11.8±1.9 nM for rhCETP and C13S CETP mutant, respectively.

Application

Products | Products > Disease Areas > Infection | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Coronavirus Infection | Products > Disease Areas > Cardiovascular Disease | Products > Disease Areas > SARS-CoV-2 Infection | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > PCSK9

Product Information

• Catalog No.: HY-12090
• CAS No.: 875446-37-0
• Molecular Formula: C30H25F10NO3
• Molecular Weight: 637.51
• Purity: 99.25%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 2.75 mg/mL (4.31 mM); Clear solution
• Availability: In-stock

Source

Original product source